Attached files

file filename
EX-3.2 - EXHIBIT 3.2 - Avanos Medical, Inc.exhibit32.htm


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 
FORM 8-K 
 


CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report: January 5, 2017
(Date of earliest event reported)

 
halyardhealthlogoa09.jpg
Halyard Health, Inc.
(Exact name of registrant as specified in its charter)
 

Delaware
001-36440
46-4987888
(State or other jurisdiction of incorporation)
(Commission file number)
(I.R.S. Employer Identification No.)
 
 
 
5405 Windward Parkway
Suite 100 South
Alpharetta, Georgia
 
30004
(Address of principal executive offices)
 
(Zip code)

Registrant’s telephone number, including area code: (678) 425-9273




Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))





Item 5.03    Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
On October 27, 2016, the Board of Directors of the Company approved the amendment and restatement of Article I, Section 1.1 of the Company’s second amended and restated by-laws to read as follows: “Section 1.1 Delaware Office. The registered office of the Corporation in the State of Delaware shall be located in the City of Wilmington, County of New Castle, and the name and address of its registered agent is Corporation Service Company, 2711 Centerville Road. Suite 400, Wilmington, 19808.”
A copy of this amendment is attached to this Form 8-K as Exhibit 3.2.
Item 9.01    Financial Statements and Exhibits.
The following materials are filed as exhibits to this Current Report on Form 8-K:

Exhibit
Number
 
Description
3.2
 
Halyard Health, Inc. Amendment to Amended and Restated Bylaws






SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
 
 
HALYARD HEALTH, INC.
 
 
 
 
 
Date:
January 5, 2017
 
By:
/s/ S. Ross Mansbach
 
 
 
 
S. Ross Mansbach
Vice President, Deputy General Counsel and Corporate Secretary